Suzhou Highfine Biotech Co (SZSE:301393) Interest Expense : ¥-0.1 Mil (TTM As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Suzhou Highfine Biotech Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Suzhou Highfine Biotech Co's interest expense for the three months ended in Mar. 2025 was ¥ -0.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-0.1 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Suzhou Highfine Biotech Co's Operating Income for the three months ended in Mar. 2025 was ¥ 31.7 Mil. Suzhou Highfine Biotech Co's Interest Expense for the three months ended in Mar. 2025 was ¥ -0.0 Mil. Suzhou Highfine Biotech Co's Interest Coverage for the quarter that ended in Mar. 2025 was 1,173.52. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Suzhou Highfine Biotech Co Interest Expense Historical Data

The historical data trend for Suzhou Highfine Biotech Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Highfine Biotech Co Interest Expense Chart

Suzhou Highfine Biotech Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-0.04

-0.09

-0.24

-0.05

-0.09

Suzhou Highfine Biotech Co Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Interest Expense	Get a 7-Day Free Trial															-0.02	-0.01	-0.01	-0.06	-0.03

Suzhou Highfine Biotech Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.1 Mil.

Suzhou Highfine Biotech Co (SZSE:301393) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Suzhou Highfine Biotech Co's Interest Expense for the three months ended in Mar. 2025 was ¥-0.0 Mil. Its Operating Income for the three months ended in Mar. 2025 was ¥31.7 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2025 was ¥1.3 Mil.

Suzhou Highfine Biotech Co's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2025 )	/	Interest Expense (Q: Mar. 2025 )
	=	-1	*	31.685	/	-0.027
	=	1,173.52

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Suzhou Highfine Biotech Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.

Suzhou Highfine Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Suzhou Highfine Biotech Co Ltd (SZSE:301393) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

No. 32 Hongxi Road, F-12 Standard Factory Building, High-tech Zone, Jiangsu Province, Suzhou, CHN, 215151

Website

https://www.highfine.com

Suzhou Highfine Biotech Co Ltd is a high-tech enterprise that provides characteristic raw materials for global pharmaceutical research and development and raw material drug production companies. The products are mainly used in the fields of peptide, nucleotide and pharmaceutical synthesis. The product range covers peptide synthesis reagents for characteristic amide bond formation, molecular building blocks, protein reagents, liposome and lipid nanoparticle pharmaceutical reagents, ionic liquids , PROTAC reagents and nucleotide reagents and other types.

Executives

Dong Sheng Jun	Directors, executives
Lu Xue Gen	Directors, executives
Lv Min Jie	Directors, executives
Xu Jie	Directors, executives

Suzhou Highfine Biotech Co Headlines

No Headlines